1-107964851-A-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_006113.5(VAV3):āc.19T>Gā(p.Cys7Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000467 in 1,607,960 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00022 ( 0 hom., cov: 32)
Exomes š: 0.00049 ( 1 hom. )
Consequence
VAV3
NM_006113.5 missense
NM_006113.5 missense
Scores
10
8
1
Clinical Significance
Conservation
PhyloP100: 5.44
Genes affected
VAV3 (HGNC:12659): (vav guanine nucleotide exchange factor 3) This gene is a member of the VAV gene family. The VAV proteins are guanine nucleotide exchange factors (GEFs) for Rho family GTPases that activate pathways leading to actin cytoskeletal rearrangements and transcriptional alterations. This gene product acts as a GEF preferentially for RhoG, RhoA, and to a lesser extent, RAC1, and it associates maximally with the nucleotide-free states of these GTPases. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.78
BS2
High AC in GnomAd4 at 34 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VAV3 | NM_006113.5 | c.19T>G | p.Cys7Gly | missense_variant | 1/27 | ENST00000370056.9 | NP_006104.4 | |
VAV3-AS1 | NR_046653.1 | n.62+347A>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VAV3 | ENST00000370056.9 | c.19T>G | p.Cys7Gly | missense_variant | 1/27 | 1 | NM_006113.5 | ENSP00000359073 | P1 | |
VAV3 | ENST00000527011.5 | c.19T>G | p.Cys7Gly | missense_variant | 1/28 | 1 | ENSP00000432540 | |||
VAV3-AS1 | ENST00000438318.1 | n.62+347A>C | intron_variant, non_coding_transcript_variant | 2 | ||||||
VAV3 | ENST00000490388.2 | c.4T>G | p.Cys2Gly | missense_variant | 1/20 | 2 | ENSP00000433559 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 151958Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
34
AN:
151958
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000268 AC: 65AN: 242264Hom.: 0 AF XY: 0.000266 AC XY: 35AN XY: 131716
GnomAD3 exomes
AF:
AC:
65
AN:
242264
Hom.:
AF XY:
AC XY:
35
AN XY:
131716
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000492 AC: 717AN: 1456002Hom.: 1 Cov.: 31 AF XY: 0.000492 AC XY: 356AN XY: 724122
GnomAD4 exome
AF:
AC:
717
AN:
1456002
Hom.:
Cov.:
31
AF XY:
AC XY:
356
AN XY:
724122
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000224 AC: 34AN: 151958Hom.: 0 Cov.: 32 AF XY: 0.000216 AC XY: 16AN XY: 74242
GnomAD4 genome
AF:
AC:
34
AN:
151958
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74242
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
9
ExAC
AF:
AC:
25
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.19T>G (p.C7G) alteration is located in exon 1 (coding exon 1) of the VAV3 gene. This alteration results from a T to G substitution at nucleotide position 19, causing the cysteine (C) at amino acid position 7 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
M;M
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at